Bulletin
Investor Alert

New York Markets Open in:

Deciphera Pharmaceuticals Inc.

NAS: DCPH

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Oct 15, 2021, 7:12 p.m.

/zigman2/quotes/203556943/composite

$

35.00

Change

+0.17 +0.49%

Volume

Volume 7,972

Quotes are delayed by 20 min

/zigman2/quotes/203556943/composite

Previous close

$ 34.69

$ 34.83

Change

+0.14 +0.40%

Day low

Day high

$34.12

$35.70

Open

52 week low

52 week high

$26.20

$68.40

Open

James A. Bristol

Currently, James A. Bristol occupies the position of Chairman of Deciphera Pharmaceuticals, Inc. and Co-Chairman for Deciphera Pharmaceuticals LLC (a subsidiary of Deciphera Pharmaceuticals, Inc.). He is also on the board of Erasca, Inc. and Trustee at Gordon Research Conferences.

In his past career Dr. Bristol occupied the position of Senior Vice President-Worldwide Discovery Research at Pfizer Inc. Vice President-Discovery Research at Warner-Lambert Co. and Vice President-Discovery Research at Pfizer (St. Louis) (both are subsidiaries of Pfizer Inc.), Executive-in-Residence at Oxford Bioscience Partners and Member of The Polycystic Kidney Disease Research Foundation.

James A. Bristol received a doctorate from the University of New Hampshire and an undergraduate degree from Bates College.

Transactions

Date Shares Transaction Value
04/20/2021 1,700   Disposition at $45.6 per share. 77,520
04/20/2021 1,700   Derivative/Non-derivative trans. at $3.95 per share. 6,715
04/19/2021 1,300   Disposition at $46.66 per share. 60,658
04/19/2021 4,000   Disposition at $46.13 per share. 184,520
04/19/2021 5,300   Derivative/Non-derivative trans. at $3.95 per share. 20,935
04/12/2021 5,217   Disposition at $44.09 per share. 230,018
04/12/2021 9,483   Disposition at $43.7 per share. 414,408
04/12/2021 14,700   Derivative/Non-derivative trans. at $3.95 per share. 58,065
01/15/2021 600   Disposition at $51.11 per share. 30,666
01/15/2021 6,400   Disposition at $50.21 per share. 321,344
01/15/2021 7,000   Derivative/Non-derivative trans. at $3.95 per share. 27,650
10/09/2020 200   Disposition at $55.43 per share. 11,086
10/09/2020 3,971   Disposition at $54.53 per share. 216,539
10/09/2020 19,370   Disposition at $53.35 per share. 1,033,390
10/09/2020 23,541   Derivative/Non-derivative trans. at $1.89 per share. 44,492
07/09/2020 301   Disposition at $57.02 per share. 17,164
07/09/2020 1,829   Disposition at $56.24 per share. 102,863
07/09/2020 9,050   Disposition at $55.15 per share. 499,108
07/09/2020 12,361   Disposition at $54.65 per share. 675,529
07/09/2020 7,217   Derivative/Non-derivative trans. at $1.89 per share. 13,640
07/09/2020 16,324   Derivative/Non-derivative trans. at $1.89 per share. 30,852
04/09/2020 536   Disposition at $45.88 per share. 24,592
04/09/2020 11,012   Disposition at $44.18 per share. 486,511
04/09/2020 5,621   Disposition at $43.93 per share. 246,931
04/09/2020 6,373   Disposition at $42.97 per share. 273,848
04/09/2020 23,542   Derivative/Non-derivative trans. at $1.89 per share. 44,494
01/03/2020 1,810   Disposition at $58.17 per share. 105,288
01/03/2020 5,250   Disposition at $57.21 per share. 300,353
01/03/2020 729   Disposition at $55.96 per share. 40,795
01/03/2020 7,989   Derivative/Non-derivative trans. at $1.89 per share. 15,099
01/03/2020 200   Disposition at $58.72 per share. 11,744
01/02/2020 300   Disposition at $61.87 per share. 18,561
01/02/2020 365   Disposition at $59.38 per share. 21,674
01/02/2020 5,347   Disposition at $58.08 per share. 310,554
01/02/2020 9,541   Disposition at $57.51 per share. 548,703
01/02/2020 15,553   Derivative/Non-derivative trans. at $1.89 per share. 29,395
11/01/2019 25,000   Disposition at $45.07 per share. 1,126,750
11/01/2019 25,000   Derivative/Non-derivative trans. at $1.89 per share. 47,250
08/13/2019 100   Disposition at $42.9 per share. 4,290
08/13/2019 700   Disposition at $42.05 per share. 29,435
08/13/2019 12,687   Disposition at $40.5 per share. 513,824
08/13/2019 11,513   Disposition at $39.24 per share. 451,771
08/13/2019 25,000   Derivative/Non-derivative trans. at $1.89 per share. 47,250
02/15/2019 17,782   Disposition at $28.04 per share. 498,608
02/15/2019 17,782   Derivative/Non-derivative trans. at $1.89 per share. 33,607
02/14/2019 1,101   Disposition at $28.01 per share. 30,840
02/14/2019 1,101   Derivative/Non-derivative trans. at $1.89 per share. 2,080
02/13/2019 2,922   Disposition at $28.01 per share. 81,846
02/13/2019 2,922   Derivative/Non-derivative trans. at $1.89 per share. 5,522
02/12/2019 600   Disposition at $28 per share. 16,800
02/12/2019 600   Derivative/Non-derivative trans. at $1.89 per share. 1,134
02/05/2019 2,595   Disposition at $28.02 per share. 72,712
02/05/2019 2,595   Derivative/Non-derivative trans. at $1.89 per share. 4,904

Officers and Executives

Mr. Steven L. Hoerter
President, Chief Executive Officer & Director
Mr. Thomas P. Kelly
Chief Financial Officer, Treasurer & Executive VP
Dr. Matthew L. Sherman
Chief Medical Officer & Executive Vice President
Dr. Daniel L. Flynn
Chief Scientific Officer & Executive VP
Dr. Stephen B. Ruddy
Chief Technical Officer
Mr. Eric Haltom
Senior Vice President-Clinical Operations
Mr. Daniel C. Martin
Chief Commercial Officer
Ms. Jennifer Robinson
Head-Investor Relations
Ms. Caroline Chevalier
Vice President-Human Resources
Mr. Jeffrey M. Held
General Counsel & Senior Vice President
Mr. Jama Pitman
Vice President-Regulatory & Quality Assurance
Dr. James A. Bristol
Chairman
Dr. Susan L. Kelley
Independent Director
Mr. Ron Squarer
Independent Director
Mr. Franklin S. Friedman
Independent Director
Ms. Patricia L. Allen
Independent Director
Dr. Edward J. Benz
Independent Director
Mr. John R. Martin
Independent Director
Mr. Dennis L. Walsh
Independent Director
Trending Tickers
  • /zigman2/quotes/200467500/composite NVDA+6.01%
  • /zigman2/quotes/200164174/composite SNOA+85.40%
  • /zigman2/quotes/202092269/composite ENSC+35.46%
  • /zigman2/quotes/226465160/composite ALF-14.72%
  • /zigman2/quotes/207732364/composite MSFT+1.66%
X
Powered by StockTwits
Link to MarketWatch's Slice.